Search for Clinical Trial Results
Ovarian Epithelial Cancer - 25 Studies Found
Status | Study |
Not yet recruiting |
Study Name: Optimisation of Disease Management in Patients With Epithelial Ovarian Cancer in France Condition: Ovarian Epithelial Cancer Date: 2016-11-28 Interventions: Other: Patient with ovarian epithelial cancer |
Completed |
Study Name: Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer Condition:
|
Withdrawn |
Study Name: Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression Condition: Ovarian Carcinoma Date: 2008-04-10 Interventions: Drug: Fondaparinux Arixtra 2.5 mg by subcutaneous injection once daily for 8 weeks or until disease recu |
Recruiting |
Study Name: Safety and Efficacy Study of Daily SPL-108 Injections In Conjunction With Paclitaxel in Women With Ovarian Cancer Condition: Ovarian Epithelial Cancer Date: 2017-03-04 Interventions: Drug: SPL-108 Subcutaneous injection of 150 mg administered either one time or two times per day. |
Active, not recruiting |
Study Name: Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma Condition:
Date: 2014-04-04 Interventions:
|
Active, not recruiting |
Study Name: Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study Condition: Ovarian Carcinoma Date: 2008-07-14 Interventions:
|
Withdrawn |
Study Name: Whole Abdomen Radiation in Conjunction With Intraperitoneal Chemotherapy for the Treatment of Small Volume Recurrent Ovarian Carcinoma Limited to the Peritoneal Cavity Condition: Recurrent Ovarian Carcinoma Date: 2009-07-17 Interventions:
|
Not yet recruiting |
Study Name: p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer Condition:
Interventions: |
Not yet recruiting |
Study Name: Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer Condition: Epithelial Ovarian Cancer Date: 2012-09-04 |
Active, not recruiting |
Study Name: Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE) Condition: Ovarian Carcinoma Date: 2014-09-15 Interventions:
|